These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31062178)

  • 1. Bismuth Subsalicylate Coagulopathy in a Patient with Chronic Liver Disease.
    Yu C; Eustaquio N; Calello DP; Ruck BE; Nelson LS; Santos C
    J Med Toxicol; 2019 Jul; 15(3):198-201. PubMed ID: 31062178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic salicylate toxicity due to consumption of over-the-counter bismuth subsalicylate.
    Vernace MA; Bellucci AG; Wilkes BM
    Am J Med; 1994 Sep; 97(3):308-9. PubMed ID: 8092182
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal salicylate toxicity from bismuth subsalicylate.
    Sainsbury SJ
    West J Med; 1991 Dec; 155(6):637-9. PubMed ID: 1812638
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin and bismuth subsalicylate.
    Levy G
    Am J Dis Child; 1993 Dec; 147(12):1281. PubMed ID: 8249944
    [No Abstract]   [Full Text] [Related]  

  • 5. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.
    Mendelowitz PC; Hoffman RS; Weber S
    Ann Intern Med; 1990 Jan; 112(2):140-1. PubMed ID: 2294817
    [No Abstract]   [Full Text] [Related]  

  • 6. Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy.
    Bingham AL; Brown RO; Dickerson RN
    Nutr Clin Pract; 2013 Dec; 28(6):766-9. PubMed ID: 24163322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bismuth Subsalicylate Poisoning.
    Meaden CW; Calello DP
    N Engl J Med; 2022 Dec; 387(22):2074. PubMed ID: 36449423
    [No Abstract]   [Full Text] [Related]  

  • 8. Bismuth subsalicylate: history, chemistry, and safety.
    Bierer DW
    Rev Infect Dis; 1990; 12 Suppl 1():S3-8. PubMed ID: 2406853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
    Domenico P; Landolphi DR; Cunha BA
    J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case 1: Mysteriously Rising Salicylate Levels in a 15-year-old Girl.
    Parker V; Goldberg D; King MA
    Pediatr Rev; 2017 Jun; 38(6):280-281. PubMed ID: 28572137
    [No Abstract]   [Full Text] [Related]  

  • 12. Photo quiz. Pepto Bismol poisoning.
    Hearney EG; Fuhrer J; Marioz P
    Clin Infect Dis; 1996 Jul; 23(1):37,159. PubMed ID: 8816125
    [No Abstract]   [Full Text] [Related]  

  • 13. Salicylate absorption from a bismuth subsalicylate preparation.
    Feldman S; Chen SL; Pickering LK; Cleary TG; Ericsson CD; Hulse M
    Clin Pharmacol Ther; 1981 Jun; 29(6):788-92. PubMed ID: 7226711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
    DuPont HL
    Drug Intell Clin Pharm; 1987 Sep; 21(9):687-93. PubMed ID: 3308391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pink Prescribing: Bismuth Subsalicylate; History, Actions, Risks, and Future Use.
    OʼMalley PA
    Clin Nurse Spec; 2020; 34(2):45-47. PubMed ID: 32068631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylate toxicity from chronic bismuth subsalicylate use.
    Halani S; Wu PE
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of bismuth subsalicylate.
    Cornick NA; Silva M; Gorbach SL
    Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy and bleeding associated with salicylate toxicity.
    Hatten BW; Hendrickson RG
    Clin Toxicol (Phila); 2020 Jan; 58(1):16-19. PubMed ID: 30900477
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
    Mahony DE; Woods A; Eelman MD; Burford N; Veldhuyzen van Zanten SJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):431-3. PubMed ID: 15616328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the active pharmaceutical ingredient bismuth subsalicylate.
    Svensson Grape E; Rooth V; Nero M; Willhammar T; Inge AK
    Nat Commun; 2022 Apr; 13(1):1984. PubMed ID: 35418171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.